Understanding
Canadian study in mice offers new insight into ‘transmissible’ Alzheimer’s disease
New study finds transplanting stem cells from mice with an Alzheimer’s gene can trigger Alzheimer’s symptoms in mice without the gene.
BBC Panorama captures the promise and challenges of new Alzheimer’s treatments
BBC Panorama episode, featuring Alzheimer’s Research UK’s Dr Susan Kohlhaas, explores two breakthrough Alzheimer’s treatments and their potential impact on the NHS.
Development and sale of Alzheimer’s drug, aducanumab, ceased
The pharmaceutical company, Biogen, announced this week that it will stop developing and marketing the Alzheimer’s drug aducanumab (commercially known as Aduhelm). Aducanumab is designed to target and clear amyloid, one of the hallmark proteins that builds up in the brains of people with Alzheimer’s, at an early stage of the disease. This is similar…
Detecting Alzheimer’s disease using a blood test could be just as accurate as standard lumbar punctures, study shows
Researchers have found that a blood test for Alzheimer’s could detect the disease as accurately as standard lumbar punctures.
Dundee scientist awarded half a million pounds to fund dementia research
Race Against Dementia, in partnership with Alzheimer’s Research UK have awarded £500,000 to Dr Amy Lloyd at the University of Dundee.
Three key take-aways from this year’s Clinical Trials in Alzheimer’s Disease (CTAD) conference in Boston
Our Executive Director of Research and Partnerships, Dr Susan Kohlhaas, reflects back on the Clinical Trials in Alzheimer’s Disease (CTAD) conference and shares her excitement about what’s to come for dementia research.
Biotech founded on charity science raises £48 million to develop next-generation dementia treatments
AstronauTx, working with the UCL DDI, has received funding to develop more treatments for dementia causing diseases like Alzheimer’s
Dementia research charity awards Cardiff scientists £387k to accelerate the search for a cure
Alzheimer’s Research UK, the UK’s leading dementia research charity, has funded two researchers from Cardiff University to carry out projects aimed at finding new treatments for Alzheimer’s disease.
Dementia research charity awards Exeter scientists £370k to accelerate progress for a cure
Alzheimer’s Research UK, the UK’s leading dementia research charity, has funded three researchers from the University of Exeter to carry out projects aimed at finding new treatments, boosting early diagnosis, and understanding the disease’s causes.
“Another milestone” – successful phase 3 trial of Alzheimer’s drug, donanemab, confirmed
Promising preliminary results from a trial of the Alzheimer’s drug donanemab, first announced in May, have now been confirmed.
